Sex differences in <scp>LDL</scp>‐C reduction response to evolocumab: A propensity score matching analysis
These results suggest that males have a better response to evolocumab in term of LDL-C reduction compared to females.
Authors
- Huang Guang-ming
- Jiejiu Lu (ORCID: https://orcid.org/0000-0002-0079-0087)
- Yuqing Wei (ORCID: https://orcid.org/0000-0002-9106-774X)
- Yun He (ORCID: https://orcid.org/0000-0002-5322-7300)
- Guoping Liu
- Zhongqiu Lin
- Taotao Liu (ORCID: https://orcid.org/0000-0001-9467-920X)
- Xia Jiang (ORCID: https://orcid.org/0009-0005-6809-5629)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1002/phar.4619
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.57